BP
MRK icon

Ballentine Partners’s Merck MRK Stock Holding History

Ballentine Partners’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.74M Buy
52,463
+3,573
+7% +$418K 0.08% 87
2026
Q1 		$5.88M Buy
48,890
+719
+1% +$83K 0.08% 88
2025
Q4 		$5.07M Buy
48,171
+2,875
+6% +$270K 0.07% 99
2025
Q3 		$3.8M Sell
45,296
-3,420
-7% -$282K 0.05% 114
2025
Q2 		$3.86M Sell
48,716
-11,780
-19% -$936K 0.06% 109
2025
Q1 		$5.43M Sell
60,496
-3,013
-5% -$281K 0.09% 80
2024
Q4 		$6.32M Sell
63,509
-2,667
-4% -$275K 0.11% 69
2024
Q3 		$7.51M Sell
66,176
-8,003
-11% -$951K 0.13% 58
2024
Q2 		$9.18M Buy
74,179
+6,044
+9% +$779K 0.17% 48
2024
Q1 		$8.99M Buy
68,135
+4,694
+7% +$579K 0.17% 49
2023
Q4 		$6.92M Buy
63,441
+9,690
+18% +$1.01M 0.14% 58
2023
Q3 		$5.53M Sell
53,751
-942
-2% -$102K 0.13% 60
2023
Q2 		$6.31M Sell
54,693
-2,236
-4% -$254K 0.14% 52
2023
Q1 		$6.06M Buy
56,929
+15,114
+36% +$1.63M 0.15% 52
2022
Q4 		$4.64M Buy
41,815
+4,484
+12% +$458K 0.14% 56
2022
Q3 		$3.21M Buy
37,331
+3,897
+12% +$348K 0.11% 68
2022
Q2 		$3.05M Buy
33,434
+1,453
+5% +$129K 0.11% 70
2022
Q1 		$2.62M Buy
31,981
+628
+2% +$49.5K 0.08% 91
2021
Q4 		$2.4M Buy
31,353
+739
+2% +$58.9K 0.07% 100
2021
Q3 		$2.3M Buy
30,614
+51
+0.2% +$3.88K 0.08% 92
2021
Q2 		$2.38M Sell
30,563
-2,668
-8% -$198K 0.08% 86
2021
Q1 		$2.44M Sell
33,231
-2,177
-6% -$161K 0.09% 76
2020
Q4 		$2.76M Sell
35,408
-1,774
-5% -$136K 0.11% 66
2020
Q3 		$2.94M Buy
37,182
+5,222
+16% +$409K 0.13% 58
2020
Q2 		$2.36M Buy
31,960
+504
+2% +$37.9K 0.11% 74
2020
Q1 		$2.31M Buy
31,456
+272
+0.9% +$21.4K 0.13% 67
2019
Q4 		$2.71M Buy
31,184
+125
+0.4% +$10.3K 0.12% 72
2019
Q3 		$2.5M Buy
31,059
+10,776
+53% +$864K 0.12% 77
2019
Q2 		$1.62M Buy
20,283
+3,695
+22% +$283K 0.08% 104
2019
Q1 		$1.32M Sell
16,588
-116
-0.7% -$8.68K 0.07% 103
2018
Q4 		$1.22M Sell
16,704
-2,338
-12% -$165K 0.07% 102
2018
Q3 		$1.29M Buy
19,042
+936
+5% +$59.6K 0.07% 108
2018
Q2 		$1.05M Buy
18,106
+1,201
+7% +$67.8K 0.06% 114
2018
Q1 		$879K Sell
16,905
-3,256
-16% -$176K 0.05% 129
2017
Q4 		$1.08M Sell
20,161
-4,034
-17% -$224K 0.06% 115
2017
Q3 		$1.48M Buy
24,195
+3,962
+20% +$240K 0.08% 87
2017
Q2 		$1.2M Buy
20,233
+1,931
+11% +$118K 0.09% 106
2017
Q1 		$1.11M Buy
18,302
+1,951
+12% +$118K 0.08% 66
2016
Q4 		$918K Buy
16,351
+1,392
+9% +$81.5K 0.07% 73
2016
Q3 		$891K Sell
14,959
-993
-6% -$58.1K 0.07% 63
2016
Q2 		$877K Buy
15,952
+363
+2% +$19.3K 0.07% 74
2016
Q1 		$787K Buy
15,589
+822
+6% +$40.3K 0.07% 78
2015
Q4 		$744K Buy
14,767
+85
+0.6% +$4.29K 0.07% 71
2015
Q3 		$692K Sell
14,682
-63
-0.4% -$3.35K 0.07% 69
2015
Q2 		$801K Buy
14,745
+754
+5% +$42.3K 0.08% 62
2015
Q1 		$767K Sell
13,991
-416
-3% -$23.6K 0.08% 67
2014
Q4 		$781K Sell
14,407
-48
-0.3% -$2.67K 0.09% 64
2014
Q3 		$818K Hold
14,455
– – 0.1% 56
2014
Q2 		$798K Buy
14,455
+268
+2% +$14.6K 0.09% 59
2014
Q1 		$768K Buy
14,187
+105
+0.7% +$5.44K 0.09% 57
2013
Q4 		$673K Buy
14,082
+70
+0.5% +$3.2K 0.08% 63
2013
Q3 		$637K Buy
14,012
+3,191
+29% +$146K 0.08% 62
2013
Q2 		$479K Buy
+10,821
New +$483K 0.06% 66

Other funds holding MRK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
ORIO
Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Ballentine Partners's MRK Position: Q2 2026 in Review

Ballentine Partners increased its Merck (MRK) stake by 7.3% in Q2 2026, buying an estimated $418K and bringing the position to 52,463 shares worth $6.74M. The position accounts for 0.08% of the portfolio, ranked #87.

Ballentine Partners first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $9.18M in Q2 2024. 711 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Ballentine Partners held 52,463 shares of Merck worth $6.74M as of Q2 2026.
  • Ballentine Partners bought 3,573 Merck shares in Q2 2026, an estimated $418K.
  • Merck made up 0.08% of Ballentine Partners's portfolio in Q2 2026, its #87 holding.
  • Ballentine Partners first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • Ballentine Partners's Merck position peaked at $9.18M in Q2 2024.
  • 711 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.